Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with 211At Using Implanted Mouse Tumor
暂无分享,去创建一个
T. Watabe | Yoshiharu Yonekura | N. Tomiyama | A. Toyoshima | K. Kaneda-Nakashima | Y. Shirakami | K. Ooe | Hiroo Nakajima | Hiroshi Toki | H. Toki | M. Bando | Masako Bando
[1] H. Enderling,et al. Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system , 2022, Neoplasia.
[2] T. Watabe,et al. Comparison of the Therapeutic Effects of [211At]NaAt and [131I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model , 2021, International journal of molecular sciences.
[3] M. Bandō,et al. WAM to SeeSaw model for cancer therapy – overcoming LQM difficulties – , 2020, International journal of radiation biology.
[4] U. Ganswindt,et al. The Role of Cancer Stem Cells in Radiation Resistance , 2020, Frontiers in Oncology.
[5] W E Bolch,et al. ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals , 2019, Annals of the ICRP.
[6] T. Watabe,et al. Enhancement of 211At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer , 2019, The Journal of Nuclear Medicine.
[7] Eduardo G Moros,et al. The future of personalised radiotherapy for head and neck cancer. , 2017, The Lancet. Oncology.
[8] F. Mottaghy,et al. 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer , 2016, The Journal of Nuclear Medicine.
[9] European Society of Radiology. Summary of the European Directive 2013/59/Euratom: essentials for health professionals in radiology , 2015, Insights into Imaging.
[10] Y. Yonekura,et al. ICRP Publication 127: Radiological Protection in Ion Beam Radiotherapy , 2014 .
[11] Eva Forssell-Aronsson,et al. Biodistribution and dosimetry of free 211At, 125I- and 131I- in rats. , 2013, Cancer biotherapy & radiopharmaceuticals.
[12] I Syndikus,et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. , 2013, The New England journal of medicine.
[13] B. Wessels,et al. MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy* , 2010, Journal of Nuclear Medicine.
[14] Harald Paganetti,et al. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction , 2008, Physics in medicine and biology.
[15] J. Hendry,et al. Radiobiology for the Radiologist , 1979, British Journal of Cancer.
[16] H. Song,et al. Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy , 2014, Radiation research.
[17] Y. Yonekura,et al. Radiological protection in ion beam radiotherapy , 2014 .